Dataset containing details of the intended number of Artemether-lumefantrine (AL) treatments given to 482 Tanzanian patients. Variables include the number of doses appropriate to each person, start time when the blister pack was first opened, and the relative time that doses 1-23 were subsequently allocated, relative to the start time. Data were captured using smart blister packs of artemether-lumefantrine (AL). These blister packs looked identical to locally available AL (Coartem) but contained a microchip that recorded a time stamp when each tablet of AL was removed from the blister pack
Abstract Background Sulphadoxine-pyrimethamine (SP) is the only single dose therapy for uncomplicate...
Background: A six-dose antimalarial regimen of artemether-lumefantrine (A/L) may soon become one of ...
Background: Artemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an...
Self-report is the most common and feasible method for assessing patient adherence to medication, bu...
Self-report is the most common and feasible method for assessing patient adherence to medication, bu...
Item does not contain fulltextPURPOSE: The results of a feasibility study of blister-pack smart tech...
BackgroundSelf-report is the most common and feasible method for assessing patient adherence to medi...
The dataset contains information on individuals who attended health facilities and drug stores in Ta...
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important ...
Abstract. Measuring baseline levels of adherence and identifying risk factors for non-adherence are ...
Background: Since November 2006, Coartem® (Artemether-Lumefantrine-ALu) replaced Sulphadoxine-Pyrime...
Adherence to artemether-lumefantrine drug munity experience six and pill-counts (kappa coefficient =...
Purpose: An electronic version of the Dosepak® (EDP) which records date and time of dosing events ha...
Purpose: An electronic version of the Dosepak® (EDP) which records date and time of dosing events ha...
<p><sup>1</sup>55 patients were excluded from this analysis because data on timing of each actual do...
Abstract Background Sulphadoxine-pyrimethamine (SP) is the only single dose therapy for uncomplicate...
Background: A six-dose antimalarial regimen of artemether-lumefantrine (A/L) may soon become one of ...
Background: Artemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an...
Self-report is the most common and feasible method for assessing patient adherence to medication, bu...
Self-report is the most common and feasible method for assessing patient adherence to medication, bu...
Item does not contain fulltextPURPOSE: The results of a feasibility study of blister-pack smart tech...
BackgroundSelf-report is the most common and feasible method for assessing patient adherence to medi...
The dataset contains information on individuals who attended health facilities and drug stores in Ta...
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important ...
Abstract. Measuring baseline levels of adherence and identifying risk factors for non-adherence are ...
Background: Since November 2006, Coartem® (Artemether-Lumefantrine-ALu) replaced Sulphadoxine-Pyrime...
Adherence to artemether-lumefantrine drug munity experience six and pill-counts (kappa coefficient =...
Purpose: An electronic version of the Dosepak® (EDP) which records date and time of dosing events ha...
Purpose: An electronic version of the Dosepak® (EDP) which records date and time of dosing events ha...
<p><sup>1</sup>55 patients were excluded from this analysis because data on timing of each actual do...
Abstract Background Sulphadoxine-pyrimethamine (SP) is the only single dose therapy for uncomplicate...
Background: A six-dose antimalarial regimen of artemether-lumefantrine (A/L) may soon become one of ...
Background: Artemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an...